Additionally, a pilot study examining mechanisms of MDMA’s efficacy for treating PTSD found MDMA treatment-responsive patients showed more methylation change compared to placebo on one site of the NR3C1 gene [149]. The gene discussed is NR3C1; the disease is post-traumatic stress disorder.